By the middle of 2023, the NTAGI director anticipates having a cervical cancer vaccine available as part of the national immunization program.

The National Vaccine Action Group of India (NTAGI) chairperson, Dr. N K Arora, has stated that by the middle of 2023, the HPV vaccine protecting against cervical cancer would be available to girls in India between the ages of 9 and 14. The SII's Director of Government and Regulatory Affairs, Prakash Kumar Singh, announced at a press conference held on the sidelines of an HPV conference in South Asia that the company plans to release its CE....